| Literature DB >> 8167128 |
S J Mentzer1, J J Reilly, A L Caplan, D J Sugarbaker.
Abstract
The decreased survival of patients undergoing lung retransplantation has raised ethical concerns regarding the "fairness" of using organs for retransplantation. This emphasis on organ utility could have important consequences for the doctor-patient relationship and the practice of retransplantation. In an attempt to balance the responsibilities of individual physicians toward their patients and the responsibilities of transplantation programs toward the public resource of donated organs, we propose a limit on the percentage of organs used for experimental or innovative procedures such as retransplantation. This limit would allow the physician to function as the patient advocate, ensure that organs are realistically allocated to patients most likely to benefit from transplantation, and permit an evolving definition of the medical efficacy of retransplantation.Entities:
Mesh:
Year: 1994 PMID: 8167128
Source DB: PubMed Journal: J Heart Lung Transplant ISSN: 1053-2498 Impact factor: 10.247